Follow-up of the efficacy of topical CG428 for chemotherapy-induced nail damage in breast cancer patients undergoing adjuvant chemotherapy.
Not Applicable
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000048583
- Lead Sponsor
- agasaki Harbor Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients undergoing chemotherapy treatment for other diseases 2. Patients with pre-treatment nail symptoms 3. Patients receiving any kind of treatment for nail symptoms 4. Patients with a history of hypersensitivity to ingredients of topical agents (e.g. ethanol), cosmetics, hair growth products, etc. 5. Other patients deemed inappropriate as research subjects by the investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method